|
J Biol Chem, Vol. 273, Issue 41, 26487-26496, October 9, 1998
Mechanism of Angiotensin II-mediated Regulation of Fibronectin
Gene in Rat Vascular Smooth Muscle Cells
Kouichi
Tamura ,
Nobuo
Nyui ,
Nobuko
Tamura¶,
Takayuki
Fujita ,
Minoru
Kihara ,
Yoshiyuki
Toya ,
Izumi
Takasaki ,
Nobuyoshi
Takagi ,
Masao
Ishii ,
Kin-ichiro
Oda ,
Masatsugu
Horiuchi**, and
Satoshi
Umemura
From the Department of Internal Medicine II and
¶ Department of Dermatology, Yokohama City University School of
Medicine, Yokohama 236, Japan, the Department of Biological
Science and Technology, Science University of Tokyo, Chiba 278, Japan,
and the ** Cardiovascular Division, Department of Medicine, Brigham and
Women's Hospital, Harvard Medical School,
Boston, Massachusetts 02115
This study was performed to investigate a
mechanism of angiotensin II (Ang II)-mediated activation of the
fibronectin (FN) gene in rat vascular smooth muscle cells. Actinomycin
D and CV11974 completely inhibited Ang II-mediated increase in FN
mRNA levels. Inhibitors of protein kinase C (PKC), protein-tyrosine
kinase (PTK), phosphatidylinositol-specific phospholipase C, Ras,
phosphatidylinositol 3-kinase, p70 S6 kinase, and
Ca2+/calmodulin kinase also decreased Ang II-induced
activation of FN mRNA. In contrast, cycloheximide; PD123319; or
inhibitors of Gi, protein kinase A, or mitogen-activated
protein kinase kinase did not affect the induction. FN promoter
contained a putative AP-1 binding site (rFN/AP-1; 463 to 437), and
the results of a transient transfection and electrophoretic mobility
shift assay showed that Ang II enhanced rFN/AP-1 activity. CV11974 and
inhibitors of PKC or PTK suppressed Ang II-mediated increases in
rFN/AP-1 activity, although neither PD123319 nor a protein kinase A
inhibitor affected the induction. Furthermore, mutation of rFN/AP-1
that disrupted nuclear binding suppressed Ang II-induced transcription in the native FN promoter ( 1908 to +136) context. Thus, Ang II activates transcription of the FN gene through the Ang II type 1 receptor in vascular smooth muscle cells, at least in part, via the
activation of AP-1 by a signaling mechanism dependent on PKC and
PTK.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. M. de Cavanagh, M. Ferder, F. Inserra, and L. Ferder
Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint
Am J Physiol Heart Circ Physiol,
March 1, 2009;
296(3):
H550 - H558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Qi, X. Chen, J. Holian, E. Mreich, S. Twigg, R. E. Gilbert, and C. A. Pollock
Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells
Am J Physiol Renal Physiol,
November 1, 2006;
291(5):
F1070 - F1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Otis, S. Campbell, M. D. Payet, and N. Gallo-Payet
Angiotensin II Stimulates Protein Synthesis and Inhibits Proliferation in Primary Cultures of Rat Adrenal Glomerulosa Cells
Endocrinology,
February 1, 2005;
146(2):
633 - 642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ruperez, O. Lorenzo, L. M. Blanco-Colio, V. Esteban, J. Egido, and M. Ruiz-Ortega
Connective Tissue Growth Factor Is a Mediator of Angiotensin II-Induced Fibrosis
Circulation,
September 23, 2003;
108(12):
1499 - 1505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, Z. A. Khan, M. Cukiernik, and S. Chakrabarti
Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications
Am J Physiol Endocrinol Metab,
June 1, 2003;
284(6):
E1089 - E1097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, S. Mukherjee, C. Chakraborty, and S. Chakrabarti
High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1
Am J Physiol Cell Physiol,
February 1, 2003;
284(2):
C263 - C272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, et al.
Inhibition of Transforming Growth Factor (TGF)-beta 1-Induced Extracellular Matrix with a Novel Inhibitor of the TGF-beta Type I Receptor Kinase Activity: SB-431542
Mol. Pharmacol.,
July 1, 2002;
62(1):
58 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yokoi, M. Mukoyama, A. Sugawara, K. Mori, T. Nagae, H. Makino, T. Suganami, K. Yahata, Y. Fujinaga, I. Tanaka, et al.
Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis
Am J Physiol Renal Physiol,
May 1, 2002;
282(5):
F933 - F942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Suzuki, O. Lopez-Franco, D. Gomez-Garre, N. Tejera, C. Gomez-Guerrero, T. Sugaya, R. Bernal, J. Blanco, L. Ortega, and J. Egido
Renal Tubulointerstitial Damage Caused by Persistent Proteinuria Is Attenuated in AT1-Deficient Mice : Role of Endothelin-1
Am. J. Pathol.,
November 1, 2001;
159(5):
1895 - 1904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fujita, Y. Toya, K. Iwatsubo, T. Onda, K. Kimura, S. Umemura, and Y. Ishikawa
Accumulation of molecules involved in {alpha}1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy
Cardiovasc Res,
September 1, 2001;
51(4):
709 - 716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fiebeler, F. Schmidt, D. N. Muller, J.-K. Park, R. Dechend, M. Bieringer, E. Shagdarsuren, V. Breu, H. Haller, and F. C. Luft
Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-{{kappa}}B Activation in Angiotensin II-Induced Cardiac Injury
Hypertension,
February 1, 2001;
37(2):
787 - 793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mifune, H. Sasamura, R. Shimizu-Hirota, H. Miyazaki, and T. Saruta
Angiotensin II Type 2 Receptors Stimulate Collagen Synthesis in Cultured Vascular Smooth Muscle Cells
Hypertension,
November 1, 2000;
36(5):
845 - 850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wang, X. Yu, R. A. Cohen, and P. Brecher
Distinct Effects of N-Acetylcysteine and Nitric Oxide on Angiotensin II-induced Epidermal Growth Factor Receptor Phosphorylation and Intracellular Ca2+ Levels
J. Biol. Chem.,
April 14, 2000;
275(16):
12223 - 12230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kim and H. Iwao
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Pharmacol. Rev.,
March 1, 2000;
52(1):
11 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tamura, Y. E. Chen, M. Lopez-Ilasaca, L. Daviet, N. Tamura, T. Ishigami, M. Akishita, I. Takasaki, Y. Tokita, R. E. Pratt, et al.
Molecular Mechanism of Fibronectin Gene Activation by Cyclic Stretch in Vascular Smooth Muscle Cells
J. Biol. Chem.,
October 27, 2000;
275(44):
34619 - 34627.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|